Uncategorized

Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology

BANNOCKBURN, Ill. and DURHAM, North Carolina, February 25, 2016 – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients...